103 related articles for article (PubMed ID: 33719420)
1. Theoretical Studies of the Acid-Base Equilibria in a Model Active Site of the Human 20S Proteasome.
Uranga J; Hasecke L; Proppe J; Fingerhut J; Mata RA
J Chem Inf Model; 2021 Apr; 61(4):1942-1953. PubMed ID: 33719420
[TBL] [Abstract][Full Text] [Related]
2. Measurement of active site ionization equilibria in the 670 kDa proteasome core particle using methyl-TROSY NMR.
Velyvis A; Kay LE
J Am Chem Soc; 2013 Jun; 135(25):9259-62. PubMed ID: 23800213
[TBL] [Abstract][Full Text] [Related]
3. Cooperative Binding of the Cationic Porphyrin Tris-T4 Enhances Catalytic Activity of 20S Proteasome Unveiling a Complex Distribution of Functional States.
Santoro AM; D'Urso A; Cunsolo A; Milardi D; Purrello R; Sbardella D; Tundo GR; Diana D; Fattorusso R; Dato AD; Paladino A; Persico M; Coletta M; Fattorusso C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003385
[TBL] [Abstract][Full Text] [Related]
4. Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin.
Serrano-Aparicio N; Świderek K; Moliner V
Eur J Med Chem; 2019 Feb; 164():399-407. PubMed ID: 30611981
[TBL] [Abstract][Full Text] [Related]
5. Processing of autophagic protein LC3 by the 20S proteasome.
Gao Z; Gammoh N; Wong PM; Erdjument-Bromage H; Tempst P; Jiang X
Autophagy; 2010 Jan; 6(1):126-37. PubMed ID: 20061800
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome.
Arba M; Nur-Hidayat A; Ruslin ; Yusuf M; Sumarlin ; Hertadi R; Wahyudi ST; Surantaadmaja SI; Tjahjono DH
Comput Biol Chem; 2018 Jun; 74():230-238. PubMed ID: 29674291
[TBL] [Abstract][Full Text] [Related]
7. A unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome.
Huber EM; Heinemeyer W; Li X; Arendt CS; Hochstrasser M; Groll M
Nat Commun; 2016 Mar; 7():10900. PubMed ID: 26964885
[TBL] [Abstract][Full Text] [Related]
8. 20S proteasome hydrolysis of LLVY substrates to determine preferences for moieties in its primed substrate channel.
Muli CS; Trader DJ
Bioorg Med Chem Lett; 2023 Apr; 85():129233. PubMed ID: 36905968
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of the ubiquitin-proteasome system: lessons from yeast.
Hochstrasser M; Deng M; Kusmierczyk AR; Li X; Kreft SG; Ravid T; Funakoshi M; Kunjappu M; Xie Y
Ernst Schering Found Symp Proc; 2008; (1):41-66. PubMed ID: 19198063
[TBL] [Abstract][Full Text] [Related]
10. Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.
Raynes R; Pomatto LC; Davies KJ
Mol Aspects Med; 2016 Aug; 50():41-55. PubMed ID: 27155164
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly.
Arendt CS; Hochstrasser M
EMBO J; 1999 Jul; 18(13):3575-85. PubMed ID: 10393174
[TBL] [Abstract][Full Text] [Related]
12. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Like Proteasome System Represents a Eukaryotic-Like Pathway for Targeted Proteolysis in Archaea.
Fu X; Liu R; Sanchez I; Silva-Sanchez C; Hepowit NL; Cao S; Chen S; Maupin-Furlow J
mBio; 2016 May; 7(3):. PubMed ID: 27190215
[TBL] [Abstract][Full Text] [Related]
14. Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
Guedes RA; Serra P; Salvador JA; Guedes RC
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438821
[TBL] [Abstract][Full Text] [Related]
15. Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.
Opoku-Nsiah KA; Gestwicki JE
Transl Res; 2018 Aug; 198():48-57. PubMed ID: 30244692
[TBL] [Abstract][Full Text] [Related]
16. Support vector machine based prediction of P. falciparum proteasome inhibitors and development of focused library by molecular docking.
Subramaniam S; Mehrotra M; Gupta D
Comb Chem High Throughput Screen; 2011 Dec; 14(10):898-907. PubMed ID: 21843142
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin allosterically inhibits the proteasome.
Osmulski PA; Gaczynska M
Mol Pharmacol; 2013 Jul; 84(1):104-13. PubMed ID: 23619386
[TBL] [Abstract][Full Text] [Related]
18. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
19. Chaperone-mediated 26S proteasome remodeling facilitates free K63 ubiquitin chain production and aggresome clearance.
Nanduri P; Hao R; Fitzpatrick T; Yao TP
J Biol Chem; 2015 Apr; 290(15):9455-64. PubMed ID: 25713068
[TBL] [Abstract][Full Text] [Related]
20. [Classification and synthesis of ubiquitin-proteasome inhibitor].
Li J; Zhang DY; Wu XM
Yao Xue Xue Bao; 2009 Dec; 44(12):1313-9. PubMed ID: 21351462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
